Radius Health Inc
NASDAQ:RDUS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Radius Health Inc
NASDAQ:RDUS
|
US |
|
S
|
Sherritt International Corp
XMUN:HRT
|
CA |
|
Grapefruit USA Inc
OTC:GPFT
|
US |
|
T
|
Treatment.com International Inc
CNSX:TRUE
|
US |
|
Alsea SAB de CV
F:4FU
|
MX |
|
Eon NRG ltd
ASX:E2E
|
US |
|
S
|
Sumitomo Pharma Co Ltd
XMUN:DPM
|
JP |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RDUS's stock price target?
Not Available
RDUS does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Radius Health Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 3 years is 6%.